Work

Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease

Year: 1997

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Archives of Neurology

DOI: 10.1001/archneur.1997.00550160091022

Authors: N. C. Bodick, W. W. Offen, A. I. Levey, N. R. Cutler, S. G. Gauthier, A. Satlin, H. E. Shannon, G. D. Tollefson, K. Rasmussen, F. P. Bymaster, D. J. Hurley, W. Z. Potter, S. M. Paul

Institutions: Eli Lilly (United States), Emory University, McGill University, Harvard University, Washington University in St. Louis

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2067418199

FWCI: 24.91

Cites: 54

Cited by: 702

Related to: 10